Triple Therapy of Umeclidinium + Inhaled Corticosteroids/Long-Acting Beta2 Agonists for Patients with COPD: Pooled Results of Randomized Placebo-Controlled Trials
Crossref DOI link: https://doi.org/10.1007/s41030-016-0012-4
Published Online: 2016-02-22
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Siler, Thomas M.
Kerwin, Edward
Tombs, Lee
Fahy, William A.
Naya, Ian
Funding for this research was provided by:
GlaxoSmithKline
License valid from 2016-02-22